IRIS
MACCARRONE, MAURO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 22.989
AS - Asia 4.218
EU - Europa 2.381
SA - Sud America 358
Continente sconosciuto - Info sul continente non disponibili 232
AF - Africa 42
OC - Oceania 9
Totale 30.229
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 22.818
SG - Singapore 2.778
CN - Cina 539
IT - Italia 386
DE - Germania 327
RU - Federazione Russa 320
BR - Brasile 289
UA - Ucraina 279
VN - Vietnam 219
HK - Hong Kong 217
IE - Irlanda 205
FR - Francia 185
SE - Svezia 147
GB - Regno Unito 141
BD - Bangladesh 123
PL - Polonia 117
KR - Corea 111
NL - Olanda 91
JP - Giappone 85
CA - Canada 74
FI - Finlandia 71
IN - India 34
MX - Messico 28
CZ - Repubblica Ceca 25
ZA - Sudafrica 23
AR - Argentina 18
JM - Giamaica 16
ES - Italia 14
IQ - Iraq 13
CR - Costa Rica 12
BE - Belgio 11
CO - Colombia 10
EC - Ecuador 10
EU - Europa 10
ID - Indonesia 10
KG - Kirghizistan 10
AT - Austria 9
AU - Australia 8
CL - Cile 8
GT - Guatemala 8
LT - Lituania 8
RS - Serbia 8
TR - Turchia 8
IR - Iran 7
TT - Trinidad e Tobago 7
UZ - Uzbekistan 7
VE - Venezuela 7
CH - Svizzera 6
HN - Honduras 6
IL - Israele 6
PH - Filippine 6
PY - Paraguay 6
CW - ???statistics.table.value.countryCode.CW??? 5
DK - Danimarca 5
NP - Nepal 5
SV - El Salvador 5
AE - Emirati Arabi Uniti 4
DM - Dominica 4
KZ - Kazakistan 4
PE - Perù 4
PR - Porto Rico 4
SA - Arabia Saudita 4
TN - Tunisia 4
TW - Taiwan 4
BB - Barbados 3
BO - Bolivia 3
DZ - Algeria 3
EE - Estonia 3
EG - Egitto 3
JO - Giordania 3
NI - Nicaragua 3
OM - Oman 3
PK - Pakistan 3
PT - Portogallo 3
RO - Romania 3
TH - Thailandia 3
UY - Uruguay 3
AL - Albania 2
AZ - Azerbaigian 2
BG - Bulgaria 2
BH - Bahrain 2
CY - Cipro 2
GR - Grecia 2
HR - Croazia 2
HU - Ungheria 2
MA - Marocco 2
NG - Nigeria 2
NO - Norvegia 2
QA - Qatar 2
A2 - ???statistics.table.value.countryCode.A2??? 1
BY - Bielorussia 1
CG - Congo 1
ET - Etiopia 1
GP - Guadalupe 1
IS - Islanda 1
KE - Kenya 1
KH - Cambogia 1
KW - Kuwait 1
LK - Sri Lanka 1
LV - Lettonia 1
Totale 30.007
Salva come PNG Salva come JPEG
Città #
Woodbridge 5.865
Wilmington 5.561
Houston 4.810
Fairfield 804
Singapore 687
Ashburn 643
Ann Arbor 544
Chandler 375
San Jose 358
Seattle 297
Beijing 250
Cambridge 249
Jacksonville 245
Hong Kong 210
Dublin 201
Medford 157
New York 135
Council Bluffs 131
Santa Clara 127
Kraków 100
The Dalles 100
Los Angeles 98
Rome 77
Tokyo 75
Lawrence 74
Ho Chi Minh City 72
Dearborn 63
Hanoi 56
Dallas 55
Buffalo 52
Milan 43
Moscow 40
Mülheim 37
Lauterbourg 36
San Diego 35
São Paulo 33
Menlo Park 31
Munich 30
Phoenix 29
Zhengzhou 29
Orem 28
Brno 24
Chicago 24
North Bergen 24
Brooklyn 23
London 21
Montreal 20
Denver 19
Atlanta 18
Nuremberg 18
Norwalk 17
Redwood City 17
Chennai 16
Frankfurt am Main 16
San Mateo 16
Falls Church 15
Saint Petersburg 15
Stockholm 15
Toronto 15
University Park 15
Mountain View 14
San Francisco 14
Warsaw 14
Verona 13
Bari 12
Redondo Beach 12
Brussels 11
Columbus 11
Helsinki 11
Johannesburg 11
Kunming 11
San José 11
Da Nang 10
Mexico City 10
Nanjing 10
Palo Alto 10
Boardman 9
Boston 9
Guangzhou 9
Seoul 9
Curitiba 8
Haiphong 8
Miami 8
Naples 8
Nürnberg 8
Poplar 8
Tampa 8
Catania 7
Kingston 7
Rio de Janeiro 7
Salt Lake City 7
Shanghai 7
Belgrade 6
Biên Hòa 6
Bologna 6
Carrboro 6
Charlotte 6
Detroit 6
Hefei 6
Manchester 6
Totale 23.550
Salva come PNG Salva come JPEG
Nome #
Distinct modulation of human myeloid and plasmacytoid dendritic cells by anandamide in multiple sclerosis 682
The (endo)cannabinoid system in multiple sclerosis and amyotrophic lateral sclerosis 629
Urinary N-acetyl-beta-D-glucosaminidase concentration in patients with spinal cord injury: relationship with urodynamic parameters 622
TRPV1 channels facilitate glutamate transmission in the striatum 622
Lack of effect of cannabis-based treatment on clinical and laboratory measures in multiple sclerosis 621
The (AAT)n repeat of the cannabinoid CB1 receptor gene influences disease progression in relapsing multiple sclerosis. 618
Experimental parkinsonism alters endocannabinoid degradation: implications for striatal glutamatergic transmission 615
Subventricular zone neural progenitors protect striatal neurons from glutamatergic excitotoxicity 601
Cannabinoids therapeutic use: what is our current understanding following the introduction of THC, THC:CBD oromucosal spray and others? 593
Preservation of striatal cannabinoid CB1 receptor function correlates with the antianxiety effects of fatty acid amide hydrolase inhibition 590
Levodopa treatment reverses endocannabinoid system abnormalities in experimental parkinsonism 565
Abnormal mGlu 5 receptor/endocannabinoid coupling in mice lacking FMRP and BC1 RNA 530
Cerebrospinal fluid levels of the endocannabinoid anandamide are reduced in patients with untreated newly diagnosed temporal lobe epilepsy. 529
Downstream effects of endocannabinoid on blood cells: Implications for health and disease 506
TRPV1 channels regulate cortical excitability in humans 502
Age-related changes of anandamide metabolism in CB1 cannabinoid receptor knockout mice: correlation with behaviour 501
Chronic cocaine sensitizes striatal GABAergic synapses to the stimulation of cannabinoid CB1 receptors 501
High endogenous cannabinoid levels in the cerebrospinal fluid of untreated Parkinson's disease patients 501
Interaction between interleukin-1β and type-1 cannabinoid receptor is involved in anxiety-like behavior in experimental autoimmune encephalomyelitis 494
Abnormal sensitivity to cannabinoid receptor stimulation might contribute to altered gamma-aminobutyric acid transmission in the striatum of R6/2 Huntington's disease mice 488
Type-1 cannabinoid receptors colocalize with caveolin-1 in neuronal cells 486
Abnormal sensitivity of cannabinoid CB1 receptors in the striatum of mice with experimental amyotrophic lateral sclerosis 480
Modulation of monocytes by bioactive lipid anandamide in multiple sclerosis involves distinct Toll-like receptors 479
The brain cytoplasmic RNA BC1 regulates dopamine D2 receptor-mediated transmission in the striatum 473
Brain-derived neurotrophic factor controls cannabinoid CB1 receptor function in the striatum 473
A critical interaction between dopamine D2 receptors and endocannabinoids mediates the effects of cocaine on striatal gabaergic Transmission 464
Type-1 (CB1) cannabinoid receptor promotes neuronal differentiation and maturation of neural stem cells . 452
Trans-crocetin improves amyloid-β degradation in monocytes from Alzheimer's Disease patients 452
Cannabinoid CB1 receptors regulate neuronal TNF-α effects in experimental autoimmune encephalomyelitis 450
GADD153 and 12-lipoxygenase mediate fenretinide-induced apoptosis of neuroblastoma 450
Interleukin-1β Causes Anxiety by Interacting with the Endocannabinoid System 450
Structure-to-function relationship of mini-lipoxygenase, a 60-kDa fragment of soybean lipoxygenase-1 with lower stability but higher enzymatic activity 449
Effects of palmitoylation of Cys(415) in helix 8 of the CB(1) cannabinoid receptor on membrane localization and signalling 447
HIV-1 coat glycoprotein gp120 induces apoptosis in rat brain neocortex by deranging the arachidonate cascade in favor of prostanoids 446
Dopamine-dependent CB1 receptor dysfunction at corticostriatal synapses in homozygous PINK1 knockout mice 444
The endocannabinoid system in peripheral lymphocytes as a mirror of neuroinflammatory diseases 441
Endocannabinoids limit metabotropic glutamate 5 receptor-mediated synaptic inhibition of striatal principal neurons 440
Transient receptor potential vanilloid 1 channels modulate the synaptic effects of TNF-α and of IL-1β in experimental autoimmune encephalomyelitis 437
The endocannabinoid pathway in Huntington's disease: a comparison with other neurodegenerative diseases 431
Pre- and postsynaptic type-1 cannabinoid receptors control the alterations of glutamate transmission in experimental autoimmune encephalomyelitis 427
The endocannabinoid system in targeting inflammatory neurodegenerative diseases 424
Association between a genetic variant of type-1 cannabinoid receptor and inflammatory neurodegeneration in multiple sclerosis 420
Comment on "Cannabinoid receptor and N-acyl phosphatidylethanolamine phospholipase D--evidence for altered expression in multiple sclerosis" 418
Stimulation of autophagy by rapamycin protects neurons from remote degeneration after acute focal brain damage 416
Altered anandamide degradation in attention-deficit/hyperactivity disorder 413
Exploitation of the HIV-1 coat glycoprotein, gp120, in neurodegenerative studies in vivo 411
Cannabinoid receptor signaling in neurodegenerative diseases: a potential role for membrane fluidity disturbance 408
The endocannabinoid system and its therapeutic exploitation in multiple sclerosis: Clues for other neuroinflammatory diseases 406
Functional characterization of putative cholesterol binding sequence (CRAC) in human type-1 cannabinoid receptor 402
In vitro and in vivo models of Huntington's disease show alterations in the endocannabinoid system 397
null 393
Lipid rafts regulate 2-arachidonoylglycerol metabolism and physiological activity in the striatum 381
Early alteration of distribution and activity of hippocampal type-1 cannabinoid receptor in Alzheimer's disease-like mice overexpressing the human mutant amyloid precursor protein 301
Potential for diagnosis versus therapy monitoring of attention deficit hyperactivity disorder: a new epigenetic biomarker interacting with both genotype and auto-immunity 298
Advances in the discovery of fatty acid amide hydrolase inhibitors: what does the future hold? 282
CSF levels of the endocannabinoid anandamide are reduced in patients with untreated narcolepsy type 1: a pilot study 274
Activity-based protein profiling reveals off-target proteins of the FAAH inhibitor BIA 10-2474 244
From Traumatic Childhood to Cocaine Abuse: The Critical Function of the Immune System 231
Essential Dietary Bioactive Lipids in Neuroinflammatory Diseases 214
Cannabinoid CB2 receptor ligand profiling reveals biased signalling and off-target activity 211
The endocannabinoid hydrolase FAAH is an allosteric enzyme 187
Platelet activation: a new vascular activity of anandamide [2] 183
Development of novel multipotent compounds modulating endocannabinoid and dopaminergic systems 170
Characterization of Endocannabinoid System and Interleukin Profiles in Ovine AEC: Cannabinoid Receptors Type-1 and Type-2 as Key Effectors of Pro-Inflammatory Response 170
Assay of NAPE-PLD Activity 158
The novel, orally available and peripherally restricted selective cannabinoid CB2 receptor agonist LEI-101 prevents cisplatin-induced nephrotoxicity 146
Palmitoylation of cysteine 415 of CB1 receptor affects ligand-stimulated internalization and selective interaction with membrane cholesterol and caveolin 1 137
Lipid Discovery by Combinatorial Screening and Untargeted LC-MS/MS 134
Biochimica del sangue 121
FAAH Modulators from Natural Sources: A Collection of New Potential Drugs 120
Plant-Derived and Endogenous Cannabinoids in Epilepsy 120
Chemical proteomics reveals off-targets of the anandamide reuptake inhibitor WOBE437 102
Dynamic changes of anandamide in the cerebrospinal fluid of Parkinson's disease patients 101
Conformational Dynamics of Lipoxygenases and Their Interaction with Biological Membranes 97
Computational and Experimental Drug Repurposing of FDA-Approved Compounds Targeting the Cannabinoid Receptor CB1 94
Endomorphin-1 prevents lipid accumulation via CD36 down-regulation and modulates cytokines release from human lipid-laden macrophages 92
Fatty acid amide hydrolase, anandamide, and neurological diseases 90
Selective Fatty Acid Amide Hydrolase Inhibitors as Potential Novel Antiepileptic Agents 87
Effects of Long-Term Oral Administration of N-Palmitoylethanolamine in Subjects with Mild Cognitive Impairment: Study Protocol 86
Radiometric Assay of NAPE-PLD Activity 83
Endocannabinoids and platelets - Signalling pathways 83
Recent Advances on Type-2 Cannabinoid (CB2) Receptor Agonists and their Therapeutic Potential 81
In silico and in vitro analysis of major cannabis-derived compounds as fatty acid amide hydrolase inhibitors 80
DNA-Protein-Interaction (DPI)-ELISA Assay for PPAR-γ Receptor Binding 71
Endocannabinoids and platelets - Differentiation 65
RG7774 (Vicasinabin), an orally bioavailable cannabinoid receptor 2 (CB2R) agonist, decreases retinal vascular permeability, leukocyte adhesion, and ocular inflammation in animal models 46
Totale 30.229
Salva come PNG Salva come JPEG
Categoria #
all - tutte 71.227
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 71.227
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022655 0 0 0 42 19 70 36 33 53 104 76 222
2022/2023937 107 81 19 122 69 230 73 60 87 4 64 21
2023/2024297 28 11 14 15 27 84 8 23 2 3 24 58
2024/20253.245 86 397 175 101 37 139 152 78 160 123 1.052 745
2025/20263.358 246 181 365 316 379 112 394 377 327 282 235 144
2026/20271.341 264 147 557 373 0 0 0 0 0 0 0 0
Totale 30.229